Showing results (11-20 of 96) with videos related to
Sort By:
Pageof 10
Magnetic Resonance Imaging|June 25, 2014
Assessment of T1, T1ρ, and T2 values of the ulnocarpal disc in healthy subjects at 3 teslaIsabel Rauscher, Benjamin Bender, Gerd Grözinger, et al.EJNMMI Research|February 5, 2020
Pre-test 68Ga-PSMA-ligand PET/CT positivity in early biochemical recurrent prostate cancer after radical prostatectomy-validation of a prediction modelPia Kraft, Tobias Maurer, Andrei Gafita, et al.European Journal of Hybrid Imaging|May 22, 2018
Multiparametric 18F-FDG PET/MR follow-up in a patient with autoimmune pancreatitisIsabel Rauscher, Matthias Eiber, Hana Algül, et al.European Radiology|January 13, 2009
Isotropic 3D fast spin-echo imaging versus standard 2D imaging at 3.0 T of the knee--image quality and diagnostic performanceOliver Ristow, Lynne Steinbach, Gregory Sabo, et al.European Journal of Radiology|March 26, 2014
Evaluation of T1ρ as a potential MR biomarker for liver cirrhosis: comparison of healthy control subjects and patients with liver cirrhosisIsabel Rauscher, Matthias Eiber, Carl Ganter, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 26, 2024
Pattern of Failure in Patients with Biochemical Recurrence After PSMA Radioguided SurgeryLilit Schweiger, Tobias Maurer, Ricarda Simon, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 30, 2019
Matched-Pair Comparison of 68Ga-PSMA-11 PET/CT and 18F-PSMA-1007 PET/CT: Frequency of Pitfalls and Detection Efficacy in Biochemical Recurrence After Radical ProstatectomyIsabel Rauscher, Markus Krönke, Michael König, et al.Radiology|October 22, 2008
Meniscal measurements of T1rho and T2 at MR imaging in healthy subjects and patients with osteoarthritisIsabel Rauscher, Robert Stahl, Jonathan Cheng, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 25, 2025
[18F]Flotufolastat PET/MRI in Patients with Suspected Prostate Cancer: Correlation with Histopathologic Biopsy ResultsNicola Gabler, Sonja Kirchhoff, Andreas Sauter, et al.EJNMMI Research|October 14, 2024
Matched-pair analysis of mCRPC patients receiving 177Lu-labeled PSMA-targeted radioligand therapy in a 4-week versus 6-week treatment intervalAmir Karimzadeh, Charlotte-Sophie Hecker, Matthias M Heck, et al.Pageof 10